Search research articles
Contact Us
Filters
Showing results (221-230 of 345) with videos related to
Page
of 35
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 25, 2011
Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study
John F de Groot, Kathleen R Lamborn, Susan M Chang, et al.
Oncotarget
|
January 27, 2017
Genome-wide copy number aberrations and HER2 and FGFR1 alterations in primary breast cancer by molecular inversion probe microarray
Hui Chen, Rajesh R Singh, Xinyan Lu, et al.
Cell
|
July 29, 2025
Cancer immunology data engine reveals secreted AOAH as a potential immunotherapy
Lanqi Gong, Jie Luo, Emily Yang, et al.
Acta Neuropathologica
|
September 9, 2025
Pineal region high-grade neuroepithelial tumors with NTRK fusions map to the novel methylation class "diffuse high-grade glioma, IDH-wild type, subtype E"
Felipe D'Almeida Costa, João Víctor Alves de Castro, Yuri Merlotti Gomes, et al.
Frontiers in Oncology
|
February 6, 2023
Heterogeneous clinicopathological findings and patient-reported outcomes in adults with <i>MN1</i>-altered CNS tumors: A case report and systematic literature review
Stephen C Frederico, Elizabeth Vera, Zied Abdullaev, et al.
Cell
|
April 15, 2021
Synthetic lethality-mediated precision oncology via the tumor transcriptome
Joo Sang Lee, Nishanth Ulhas Nair, Gal Dinstag, et al.
Journal of Neuro-Oncology
|
June 30, 2009
Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma
Andrew D Norden, Jeffrey J Raizer, Lauren E Abrey, et al.
Acta Neuropathologica
|
February 1, 2022
High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13
Drew Pratt, Zied Abdullaev, Antonios Papanicolau-Sengos, et al.
Brain Pathology (Zurich, Switzerland)
|
May 27, 2025
cIMPACT-NOW update 10: Recommendations for defining new types for central nervous system tumor classification
Cynthia Hawkins, Kenneth Aldape, David Capper, et al.
Journal of Neuro-Oncology
|
October 9, 2017
Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02
Phioanh Leia Nghiemphu, Victoria Asuquo Ebiana, Patrick Wen, et al.
Page
of 35
Search research articles
Search
Showing results (221-230 of 345) with videos related to
Sort By:
Page
of 35
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 25, 2011
Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study
John F de Groot, Kathleen R Lamborn, Susan M Chang, et al.
Oncotarget
|
January 27, 2017
Genome-wide copy number aberrations and HER2 and FGFR1 alterations in primary breast cancer by molecular inversion probe microarray
Hui Chen, Rajesh R Singh, Xinyan Lu, et al.
Cell
|
July 29, 2025
Cancer immunology data engine reveals secreted AOAH as a potential immunotherapy
Lanqi Gong, Jie Luo, Emily Yang, et al.
Acta Neuropathologica
|
September 9, 2025
Pineal region high-grade neuroepithelial tumors with NTRK fusions map to the novel methylation class "diffuse high-grade glioma, IDH-wild type, subtype E"
Felipe D'Almeida Costa, João Víctor Alves de Castro, Yuri Merlotti Gomes, et al.
Frontiers in Oncology
|
February 6, 2023
Heterogeneous clinicopathological findings and patient-reported outcomes in adults with <i>MN1</i>-altered CNS tumors: A case report and systematic literature review
Stephen C Frederico, Elizabeth Vera, Zied Abdullaev, et al.
Cell
|
April 15, 2021
Synthetic lethality-mediated precision oncology via the tumor transcriptome
Joo Sang Lee, Nishanth Ulhas Nair, Gal Dinstag, et al.
Journal of Neuro-Oncology
|
June 30, 2009
Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma
Andrew D Norden, Jeffrey J Raizer, Lauren E Abrey, et al.
Acta Neuropathologica
|
February 1, 2022
High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13
Drew Pratt, Zied Abdullaev, Antonios Papanicolau-Sengos, et al.
Brain Pathology (Zurich, Switzerland)
|
May 27, 2025
cIMPACT-NOW update 10: Recommendations for defining new types for central nervous system tumor classification
Cynthia Hawkins, Kenneth Aldape, David Capper, et al.
Journal of Neuro-Oncology
|
October 9, 2017
Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02
Phioanh Leia Nghiemphu, Victoria Asuquo Ebiana, Patrick Wen, et al.
Page
of 35